Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 36, 2021 - Issue 1
Submit an article Journal homepage
1,715
Views
3
CrossRef citations to date
0
Altmetric
Brief Report

Three-component Castagnoli-Cushman reaction with ammonium acetate delivers 2-unsubstituted isoquinol-1-ones as potent inhibitors of poly(ADP-ribose) polymerase (PARP)

Alexander Safrygina Chemistry, Saint Petersburg State University, Saint Petersburg, RussiaView further author information
,
Petr Zhmurova Chemistry, Saint Petersburg State University, Saint Petersburg, RussiaView further author information
,
Dmitry Dar’ina Chemistry, Saint Petersburg State University, Saint Petersburg, RussiaView further author information
,
Sergey Silonovb JSC BIOCAD, Saint Petersburg, RussiaView further author information
,
Mariia Kasatkinab JSC BIOCAD, Saint Petersburg, RussiaView further author information
,
Yulia Zonisb JSC BIOCAD, Saint Petersburg, RussiaView further author information
,
Maxim Gureevc Digital Biodesign and Personalized Healthcare Research Center, Sechenov First Moscow State Medical University, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0002-0385-922XView further author information
ORCID Icon &
Mikhail Krasavina Chemistry, Saint Petersburg State University, Saint Petersburg, RussiaCorrespondence[email protected]
View further author information
 show all
Pages 1916-1921 | Received 30 Jun 2021, Accepted 11 Aug 2021, Published online: 31 Aug 2021

References

  • Park M-T, Lee S-J. Cell Cycle and Cancer. J Biochem Mol Biol 2003;36:60–5.
  • Gibson BA, Kraus WL. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat Rev Mol Cell Biol 2012;13:411–24.
  • Mateo J, Lord CJ, Serra V, et al. A decade of clinical development of PARP inhibitors in perspective. Ann Oncol 2019;30:1437–47.
  • Lord CJ, Ashworth A. PARP inhibitors: synthetic lethality in the clinic. Science 2017;355:1152–8.
  • Papeo G, Posteri H, Borghi D, et al. Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): a potent, orally available, and highly selective PARP-1 inhibitor for cancer therapy. J Med Chem 2015;58:6875–98.
  • Safrygin A, Zhmurov P, Dar’in D, et al. 1-Oxo-3,4-dihydroisoquinoline-4-carboxamides as novel druglike inhibitors of poly(ADP-ribose) polymerase (PARP) with favorable ADME characteristics. J Enzyme Inhib Med Chem. submitted.
  • Safrygin A, Bakulina O, Dar’in D, Krasavin M. Three-component reaction of homophthalic anhydride with carbonyl compounds and ammonium acetate: new developments. Synthesis 2020;52:2190–5.
  • Laws SW, Moore LC, Di Maso MJ, et al. Diastereoselective base-catalyzed formal [4 + 2] cycloadditions of N-sulfonyl imines and cyclic anhydrides. Org Lett 2017;19:2466–9.
  • Hernando E, Arrayas RG, Carretero JC. Catalytic asymmetric Mannich reaction of glycine Schiff bases with α-amido sulfones as precursors of aliphatic imines. Chem Commun 2012;48:9622–4.
  • https://bpsbioscience.com/pub/media/wysiwyg/PARPs/80580_1.pdf(PARP1).
  • https://bpsbioscience.com/pub/media/wysiwyg/PARPs/80581_1.pdf(PARP2).
  • Hughes JP, Rees S, Kalindjian SB, Philpott KL. Principles of early drug discovery. Br J Pharmacol 2011;162:1239–49.
  • Kang B-R, Wang J, Li H, et al. Synthesis and antitumor activity evaluation of 2-arylisoquinoline-1,3(2H,4H)-diones in vitro and in vivo. Med Chem Res 2014;23:1340–9.
  • Pellicciari R, Camaioni E, Costantino G, et al. On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives. ChemMedChem 2008;3:914–23.
  • Sunderland PT, Woon ECY, Dhami A, et al. 5-Benzamidoisoquinolin-1-ones and 5-(ω-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2). J Med Chem 2011;54:2049–59.
  • Gui B, Gui F, Takai T, et al. Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function. Proc Natl Acad Sci U S A 2019;116:14573–82.
  • Gleeson MP, Hersey A, Montanari D, Overington J. Probing the links between in vitro potency, ADMET and physicochemical parameters. Nat Rev Drug Discov 2011;10:197–208.
  • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3–26.
  • Calculated using Molinspiration Chemoinformatics tool (https://www.molinspiration.com/).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.